Stocks / Pharmaceuticals
LQDAPharmaceuticals
Liquidia Corporation
$68.801d +1.1%5d +1.4%settled close · 2026-09-17
Mkt cap $3.1B (3/25)β 0.8752w $37–91Shares 88.1MInd. Pharmaceutical PreparationsNasdaq since 2018Emp. 216HQ Morrisville, NCliquidia.com
Who’s talkingIdea Scout · free
Who’s talking about LQDA
No tracked investor commentary on LQDA yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 2 Nov 2026 before the open
Confirmed date · consensus EPS 0.86. Reactions below are the next settled session over the prior close.
| Report | When | EPS actual vs est. | Reaction |
|---|---|---|---|
| 12 Aug 2026 | before the open | 0.74 vs 0.76 | -9.5% |
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where LQDA’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 6 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-08-24 | ||||||
| 2026-08-13 | ||||||
| 2026-08-12 | ||||||
| 2026-07-22 | ||||||
| 2026-07-20 | ||||||
| 2026-06-11 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
LQDA is in this morning’s Brief.
Get The Brief — $20/mo →